To access this element change to forms mode OFF
Grant Award View - GA206665
A novel, dual-targeted therapeutic approach for reducing...
GA ID:
GA206665
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
20-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$1,566,077.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
A novel, dual-targeted therapeutic approach for reducing diabetes-accelerated atherosclerosis
Purpose:
Patients with diabetes are in a pro-inflammatory state and many of them develop an aggressive form of heart disease. Blood levels of the pro-inflammatory enzyme myeloperoxidase (MPO) are also elevated in these patients. This project will determine whether treatment with peptides that have anti-diabetic and anti-inflammatory properties plus an MPO inhibitor reduces heart disease in these patients more effectively than the peptides alone or an MPO inhibitor alone.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2013260
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Sydney
Town/City:
Sydney
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW
Postcode:
Multiple
Country:
AUSTRALIA